The Bright Elusive Butterfly of Value in Health Technology Development Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
ijhpm.com · 4,976 words · saved by 1 readers
N/A
http://ijhpm.com Int J Health Policy Manag 2018, 7(1), 81–85 doi 10.15171/ijhpm.2017.65 Commentary http://ijhpm.com http://ijhpm.com The Bright Elusive Butterfly of Value in Health Technology Int doi 10.15171/ijhpm.2015.188…
related reading
- Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agenciesijhpm.com
- Value Beyond Instrumentalization — Letters to a Young Technologistletterstoayoungtechnologist.com
- What is Technology? — Letters to a Young Technologistletterstoayoungtechnologist.com
- Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
- A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
- A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
- Value Beyond Instrumentalization — Letters to a Young Technologistletterstoayoungtechnologist.com
- Existential_Risk_and_Growth.pdfphiliptrammell.com
- belfercenter.org/sites/default/files/2024-09/UsingAdvanceMarketCommits.pdfbelfercenter.org
- Technology entrepreneurship and the disruption of ambition | by Matt Clifford | Entrepreneurs First | Mediummedium.com
- Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologiesjmir.org
- Hey Tech, It's Time To Build. In Healthcare. | Andreessen Horowitza16z.com